SCHEMBL3483542

SCHEMBL3483542

CCc1c(S(=O)(=O)NCP(=O)(O)O)sc2cc(OCCCN)c(OCCCN)cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16667024 0.95
Trifluoroacetic Acid SCHEMBL3483300 0.93 CA12 (0.32)
Trifluoroacetic Acid SCHEMBL3483295 0.93 CA12 (0.32)
SCHEMBL3480846 0.91
SCHEMBL3484104 0.88 CMA1 (0.33)
SCHEMBL16667387 0.87
Hydrochloric Acid SCHEMBL3951226 0.87 CMA1 (0.33)
Hydrochloric Acid SCHEMBL3951236 0.87 CMA1 (0.33)
SCHEMBL3483310 0.86
SCHEMBL16667549 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049200-B1 NOVEL INHIBITORS OF BETA-LACTAMASE METHYLGENE INC (CA) 2015-04-29 EP claimed
US-20100279983-A1 NOVEL INHIBITORS OF BETA-LACTAMASE METHYLGENE INC. 2010-11-04 US claimed
EP-2049200-A2 NOVEL INHIBITORS OF BETA-LACTAMASE MethylGene Inc. (CA) 2009-04-22 EP claimed
WO-2008073142-A2 NOVEL INHIBITORS OF BETA-LACTAMASE MERCK & CO., INC. (US) 2008-06-19 WO claimed